Biologics & Biosimilars · Oncology Therapeutics
Innovent Biologics: Risk & public record
Innovent Biologics: 198 research papers in five years.
Data updated Nov 22, 2026 · Back to the company report
What the registers and the postings say about this employer.
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Domain and mail securityinnoventbio.com · Nov 21, 2026
Spoofed mail (DMARC)
Spoofed mail is rejected · dns.google ↗
Good
Who may send its mail (SPF)
Other senders soft-fail (~all) · dns.google ↗
Good
HTTPS certificate
Valid certificate · DigiCert, Inc. · crt.sh ↗
Good
HTTPS enforced (HSTS)
Not enforced · hstspreload.org ↗
Weak
Security contact (security.txt)
No security.txt · innoventbio.com ↗
Weak
Encrypted mail delivery (MTA-STS)
No MTA-STS policy · dns.google ↗
Weak
Signed DNS (DNSSEC)
Not signed · dnsviz.net ↗
Weak
Certificate issuers (CAA)
Any authority may issue certificates · dns.google ↗
Weak
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices The domain: its DNS records, its site's headers and certificate.
Public record
Innovent Biologics: 198 research papers in five years.
Research outputpapers its people wrote, per OpenAlex
198papers in five years
11kcitations
Cancer Immunotherapy and Biomarkers
Medicine
154 papers
Monoclonal and Polyclonal Antibodies Research
Immunology and Microbiology
75 papers
Lung Cancer Treatments and Mutations
Medicine
54 papers
Immunotherapy and Immune Responses
Immunology and Microbiology
36 papers
Gastric Cancer Management and Outcomes
Medicine
31 papers
Works most with: Zhejiang University, Hunan Cancer Hospital, Anhui Provincial Hospital, First Affiliated Hospital Zhejiang University, Huazhong University of Science and Technology, Shandong First Medical University
Each line links its register: the agency's page, the EU Transparency Register, the FEC, the USPTO, CourtListener.
